McIlrath & Eck’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$25.9K 1669
2025
Q4
$25.9K Hold
100
﹤0.01% 464
2025
Q3
$22.7K Hold
100
﹤0.01% 479
2025
Q2
$20.9K Sell
100
-100
-50% -$19.3K ﹤0.01% 469
2025
Q1
$38.9K Hold
200
﹤0.01% 366
2024
Q4
$45.1K Hold
200
0.01% 336
2024
Q3
$41.7K Hold
200
0.01% 350
2024
Q2
$37.6K Hold
200
0.01% 327
2024
Q1
$36.9K Hold
200
0.01% 333
2023
Q4
$36.4K Hold
200
0.01% 312
2023
Q3
$35.3K Hold
200
0.01% 316
2023
Q2
$37.6K Hold
200
0.01% 300
2023
Q1
$39K Sell
200
-100
-33% -$18.6K 0.01% 296
2022
Q4
$55K Hold
300
0.01% 226
2022
Q3
$41K Hold
300
0.01% 274
2022
Q2
$45K Buy
+300
New +$48.7K 0.01% 250

Other funds holding MSGS

McIlrath & Eck's MSGS Position: Q1 2026 in Review

McIlrath & Eck sold out of Madison Square Garden (MSGS) in Q1 2026, closing a stake of 100 shares — an estimated $25.9K sold.

McIlrath & Eck first reported a position in MSGS in Q2 2022 and held it in 15 quarters. The position peaked at $55K in Q4 2022. 410 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • McIlrath & Eck reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
  • McIlrath & Eck sold 100 Madison Square Garden shares in Q1 2026, an estimated $25.9K.
  • McIlrath & Eck first reported a position in Madison Square Garden in Q2 2022 and held it in 15 quarters.
  • McIlrath & Eck's Madison Square Garden position peaked at $55K in Q4 2022.
  • 410 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.